🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Tirzepatide nausea management — March 2026 Page 5

Tirzepatide nausea management — March 2026

DataDave Wed, Sep 11, 2024 at 9:14 PM 30 replies 2,103 viewsPage 5 of 6
AmyNC_wife
Member
634
2,890
Jun 2024
North Carolina
Sep 13, 2024 at 2:49 AM#21
Dr.LeslieOBGYN said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Adding the part of the answer the thread has not reached. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

I would rather be corrected than agreed with, if it comes to it.

2 0JessicaM_2024, TomFromTexas
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Sep 13, 2024 at 9:43 AM#22

One concrete data point for the thread. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

3 1traveltech_sara, AttorneyGrant, DebRD_ATL
Reply Quote Save Share Report
mia_MS2
New Member
8
23
Jun 2026
Ann Arbor, MI
Sep 13, 2024 at 4:37 PM#23

One thing that is still open after Dr.LeslieOBGYN’s answer:

What distinguishes the nausea you can titrate through from the nausea that means stop?

4 2dave_SLC, FDA_TrackerJim, ricardo_MIA and 1 other
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Sep 13, 2024 at 11:30 PM#24
Dr.PulmRoch said:
If you are going to change something, change one thing and give it long enough to express itself.

I read this differently from Dr.PulmRoch, on substance rather than tone. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.

5 3VendorMark, COA_Karl, MikeFit_NJ and 2 others
Reply Quote Save Share Report
mel_PDX
Member
189
890
Dec 2024
Portland, OR
Sep 14, 2024 at 6:23 AM#25
Dr.PulmRoch said:
If you are going to change something, change one thing and give it long enough to express itself.

Agreed on adaptation, with a caveat: adaptation applies to gastric emptying and not to everything. If your problem is the aversion rather than the fullness, waiting does less, because the aversion is central and it is the mechanism working as intended.

6 4RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 3 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register